Biomerica
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biomerica generated cash of -$5,361,000, which is more than the previous year. Cash used in financing activities reached the amount of -$81,000 last year. Net change in cash is therefore -$5,549,000.
Cash Flow
| 2015 | -405.48K | -22.78K | 9.56K |
|---|---|---|---|
| 2016 | -208.78K | -95.19K | 1.10M |
| 2017 | -722.85K | -96.08K | 157.72K |
| 2018 | -1.17M | -130.34K | 1.29M |
| 2019 | -2.24M | -171.11K | 1.90M |
| 2020 | -4.29M | -118.92K | 12.37M |
| 2021 | -5.25M | -295.58K | 1.11M |
| 2022 | -480.53K | -170.33K | 2.39M |
| 2023 | -5.47M | -78K | 9.39M |
| 2024 | -5.36M | -115K | -81K |
BMRA Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.71M | 5.91M | 4.19M | 8.64M | 686.78K | 1.20M | 1.22M | 1.88M | 1.08M | 1.50M |
Operating activities | ||||||||||
Net income | -5.97M | -7.14M | -4.53M | -6.46M | -2.33M | -2.39M | -1.46M | -908.56K | -1.49M | -331.41K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 374K | 351K | 594.82K | 375.85K | 398.63K | 162.90K | 186.60K | 219.21K | 232.42K | 253.27K |
Stock-based compensation expense | 837K | 1.18M | 1.26M | 1.35M | 538.58K | 151.22K | 0 | 21.72K | 15.15K | 10.01K |
| Deferred income tax benefit | 837K | 1.18M | 1.26M | 1.35M | 538.58K | 151.22K | 0 | 21.72K | 15.15K | 10.01K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -215K | -291K | 1.36M | -455.61K | -309.09K | -670.12K | 252.50K | -132.26K | 151.15K | 348.66K |
Inventories | -115K | 534K | 1.56M | -1.90M | -717.46K | 21.38K | -457.26K | 150.47K | 137.13K | -243.37K |
Accounts payable | 246K | -80K | -403.33K | 398.37K | -12.88K | 343.99K | 319.16K | 10.44K | -30.58K | -29.13K |
Cash generated by operating activities | -5.36M | -5.47M | -480.53K | -5.25M | -4.29M | -2.24M | -1.17M | -722.85K | -208.78K | -405.48K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -51K | -78K | -170.33K | -295.58K | -118.92K | -171.11K | -130.34K | -96.08K | -95.19K | -24.68K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -115K | -78K | -170.33K | -295.58K | -118.92K | -171.11K | -130.34K | -96.08K | -95.19K | -22.78K |
Financing activities | ||||||||||
Common Stock Issued | -81K | 10.01M | 2.40M | 1.01M | 10.23M | 1.77M | 1.26M | 157.72K | 995.97K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -705K | -85K | -165.91K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -81K | 9.39M | 2.39M | 1.11M | 12.37M | 1.90M | 1.29M | 157.72K | 1.10M | 9.56K |
Net Change In Cash | -5.54M | 3.80M | 1.71M | -4.44M | 7.95M | -518.11K | -20.55K | -663.46K | 800.61K | -420.81K |
Cash at end of period | 4.17M | 9.71M | 5.91M | 4.19M | 8.64M | 686.78K | 1.20M | 1.22M | 1.88M | 1.08M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |